The European Medicines Agency
(EMA) has launched a public
consultation on the key principles
of its new PRIME scheme.
PRIME aims to strengthen
support to medicines that have
the potential to benefit patients
who presently have no treatment
options, or that may offer a major
therapeutic advantage over existing
treatments.
These are considered priority
medicines by EMA, hence the name
of the scheme.The above article was sent to subscribers in Pharmacy Daily's issue from 28 Oct 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Oct 15
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.